PHK
ACHL

Point72 Hong Kong’s Achilles Therapeutics ACHL Stock Holding History

Point72 Hong Kong’s Portfolio ACHL Stock Details ACHL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-98
Closed – – 2489
2022
Q1 		$0 Hold
98
– – ﹤0.01% 2421
2021
Q4 		$0 Hold
98
– – ﹤0.01% 2489
2021
Q3 		$1K Buy
+98
New +$645 ﹤0.01% 1905

Other funds holding ACHL

SP
Syncona Portfolio St Peter Port, Guernsey $25.7M AUM 13.32% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KHCM
Kettle Hill Capital Management New York $399M AUM 10.05% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Point72 Hong Kong's ACHL Position: Q2 2022 in Review

Point72 Hong Kong sold out of Achilles Therapeutics (ACHL) in Q2 2022, closing a stake of 98 shares.

Point72 Hong Kong first reported a position in ACHL in Q3 2021 and held it in 3 quarters. The position peaked at $1K in Q3 2021. 25 funds tracked by Wall St. Rank hold ACHL as of Q2 2022.

  • Point72 Hong Kong reported no remaining Achilles Therapeutics position as of Q2 2022 after selling out during the quarter.
  • Point72 Hong Kong sold 98 Achilles Therapeutics shares in Q2 2022.
  • Point72 Hong Kong first reported a position in Achilles Therapeutics in Q3 2021 and held it in 3 quarters.
  • Point72 Hong Kong's Achilles Therapeutics position peaked at $1K in Q3 2021.
  • 25 funds tracked by Wall St. Rank held Achilles Therapeutics as of Q2 2022.

Based on Point72 Hong Kong's 13F filing for Q2 2022, filed 15 Aug 2022.